Scytonemin And Methods Of Using Thereof

Abstract

Disclosed are compounds having a scytoneman skeleton, such as scytonemin, and methods of using thereof. Methods of using a compound having a scytoneman skeleton to inhibit, modulate, attenuate, or prevent cell-cycle progression, cell proliferation, kinase activity, or induce apoptosis are disclosed. Also disclosed are methods of treating, preventing, or inhibiting diseases and disorders associated with cell cycle progression, cell proliferation, kinase activity, tissue hyperplasia or angiogenesis, such as cancer or an inflammatory disease.


Claims
Download PDF
Document Preview
Document History
  • Publication: Dec 17, 2002
  • Application: Sep 24, 2001
    US US 96031401 A
  • Priority: Sep 24, 2001
    US US 96031401 A
  • Priority: Feb 23, 2001
    US US 79064001 A
  • Priority: Feb 25, 2000
    US US 18502900 P

Download Citation


Sign in to the Lens

Feedback